Urology Medical News about UTI

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis
Antimicrobial Agents and Chemotherapy, 08/25/09

Naber KG et al. – Doripenem was found not to be inferior to levofloxacin in terms of therapeutics and is now approved for use in the United States and Europe for the treatment of adults with cUTI, including pyelonephritis. As fluoroquinolone resistance increases, doripenem may become a more important option for successful treatment of cUTIs, including treatment of pyelonephritis.

<< Previous
Evaluating the Role of the Serotoninergic System in the Control...

Next >>
Short- and Long-Term Donor Outcomes After Kidney Donation:...

Urinary tract infections in pediatric renal transplant recipients
Pediatric Transplantation, 11/06/09 Relevance Score: 84%

Hygiene and urinary tract infections after cystectomy in 452 Swedish survivors of bladder cancer
BJU International, 11/02/09 Relevance Score: 84%

Serum Procalcitonin for Prediction of Renal Parenchymal Involvement in Children with Urinary Tract Infections
The Journal of Pediatrics, 11/02/09 Relevance Score: 84%

Prevalence of lower urinary tract infection in South Indian type 2 diabetic subjects
Indian Journal of Nephrology, 10/16/09 Relevance Score: 84%

Automated Microscopy, Dipsticks and the Diagnosis of Urinary Tract Infection
BMJ - Archives of Diseases in Childhood, 10/30/09 Relevance Score: 80%